CIBC World Market
XENE icon

CIBC World Market’s Xenon Pharmaceuticals XENE Stock Holding History

CIBC World Market’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
19,960
+1,000
+5% +$55.5K ﹤0.01% 979
2026
Q1 		$1.1M Buy
18,960
+5,500
+41% +$253K ﹤0.01% 906
2025
Q4 		$603K Hold
13,460
– – ﹤0.01% 1064
2025
Q3 		$540K Sell
13,460
-2,875
-18% -$101K ﹤0.01% 1095
2025
Q2 		$511K Hold
16,335
– – ﹤0.01% 1047
2025
Q1 		$548K Sell
16,335
-3,500
-18% -$133K ﹤0.01% 1009
2024
Q4 		$778K Hold
19,835
– – ﹤0.01% 938
2024
Q3 		$781K Sell
19,835
-16,550
-45% -$667K ﹤0.01% 876
2024
Q2 		$1.42M Sell
36,385
-935
-3% -$37.4K ﹤0.01% 726
2024
Q1 		$1.61M Sell
37,320
-572
-2% -$26.3K ﹤0.01% 699
2023
Q4 		$1.75M Sell
37,892
-7,480
-16% -$264K ﹤0.01% 638
2023
Q3 		$1.55M Buy
45,372
+4,150
+10% +$155K 0.01% 629
2023
Q2 		$1.59M Buy
41,222
+8,473
+26% +$337K 0.01% 656
2023
Q1 		$1.17M Buy
32,749
+10,199
+45% +$377K ﹤0.01% 713
2022
Q4 		$889K Sell
22,550
-750
-3% -$27.3K ﹤0.01% 793
2022
Q3 		$841K Sell
23,300
-23,587
-50% -$848K ﹤0.01% 757
2022
Q2 		$1.43M Buy
46,887
+5,550
+13% +$168K 0.01% 637
2022
Q1 		$1.26M Sell
41,337
-8,297
-17% -$248K ﹤0.01% 687
2021
Q4 		$1.55M Buy
+49,634
New +$1.48M ﹤0.01% 669

Other funds holding XENE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC World Market's XENE Position: Q2 2026 in Review

CIBC World Market increased its Xenon Pharmaceuticals (XENE) stake by 5.3% in Q2 2026, buying an estimated $55.5K and bringing the position to 19,960 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #979.

CIBC World Market first reported a position in XENE in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.75M in Q4 2023. 207 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

  • CIBC World Market held 19,960 shares of Xenon Pharmaceuticals worth $1.2M as of Q2 2026.
  • CIBC World Market bought 1,000 Xenon Pharmaceuticals shares in Q2 2026, an estimated $55.5K.
  • Xenon Pharmaceuticals made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #979 holding.
  • CIBC World Market first reported a position in Xenon Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • CIBC World Market's Xenon Pharmaceuticals position peaked at $1.75M in Q4 2023.
  • 207 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.